Adriatic
Argentina
Asia-Pacific
Australia and New Zealand
Bangladesh
Belgique (Belgium)
België (Belgium)
Brasil (Brazil)
Bulgaria
Canada
Canada
Česká republika (Czech Republic)
Chile
中国 (China)
Colombia
Costa Rica
Србија (Serbia)
Danmark (Denmark)
Deutschland (Germany)
Ecuador
España (Spain)
Europe
France
Ελλάδα (Greece)
香港特区 (Hong Kong SAR)
Indian Subcontinent
Ireland
Israel ישראל
Italia (Italy)
日本 (Japan)
Latinoamérica
Magyarország (Hungary)
México (Mexico)
Middle East and North Africa
Nederland (Netherlands)
Norge (Norway)
Österreich (Austria)
Panama
Portugal
Paraguay
Perú (Peru)
Polska (Poland)
Российская Федерация (Russia)
Puerto Rico
Romania
Schweiz (Switzerland)
Slovenská republika (Slovak Republic)
Southeast Asia
South Africa and Sub-Sahara
대한민국 (South Korea)
Suisse (Switzerland)
Suomi (Finland)
Sverige (Sweden)
台湾地区 (Taiwan)
Türkiye (Turkey)
United Kingdom
United States
Uruguay
Україна (Ukraine)
Press releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Mar 22, 2023A strategic collaboration with Cosmo Pharmaceuticals and NVIDIA delivers the GI Genius™ AI Access™ platform designed to accelerate AI innovation for healthcare. DUBLIN, March 22, 2023...
-
Dec 15, 2022
Expand URO is a prospective, multi-center, single-arm study to evaluate the safety and performance of the Hugo™ RAS system for urologic procedures DUBLIN, Dec. 15, 2022 /PRNewswire/ -- Medtronic...
-
Oct 19, 2022
Hugo™ robotic-assisted surgery system regulatory approval in Japan provides access to third largest robotics market in the world while general surgery approval in the EU and Canada open...
-
Aug 31, 2022
Partnership reflects commitment to patient safety; BioButton® wearable offers up to 1,440 vital signs measurements daily, monitoring patients transitioning from higher to lower acuity settings...
Jul 15, 2022Additional +80 GI Genius™ units to be donated for a total of 133 to 62 facilities that primarily serve communities with low screening rates or where access to the technology is not currently...